MTIX Micro Therapeutics (MM)

Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005 IRVINE, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Micro Therapeutics, Inc. (MTI) (NASDAQ:MTIX) today announced it will release its 2004 fourth quarter and full year financial results on February 10, 2005. The company also said that Tom Wilder, MTI's president and chief executive officer, and James Corbett, chairman, will host a conference call that same day at 1:00 p.m. PT (4:00 p.m. ET) to review the company's financial results and operations. The conference call will be available to interested parties through a live audio webcast at http://www.1mti.com/, where it will be archived and accessible for approximately one year. About Micro Therapeutics, Inc. MTI develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disorders. The company's primary focus is on catheter based technologies and products for the interventional neuroradiology market. MTI's products include the Sapphire(R) and NXT lines of embolic coils, the ONYX(R) liquid embolic system, and a broad line of micro catheters, guidewires, and occlusion balloons that are utilized in the treatment of cerebral vascular disorders. DATASOURCE: Micro Therapeutics, Inc. CONTACT: Thomas C. Wilder of Micro Therapeutics, Inc., +1-949-837-3700; or Rob Whetstone, or Robert Jaffe, both of PondelWilkinson Inc., +1-310-279-5980, for Micro Therapeutics, Inc. Web site: http://www.1mti.com/

Copyright